Escalon Medical Corp.

Escalon Medical Corp.

OOTC:ESMC
0.18
USD
+0.01
(+3.76%)
0.17EPS
1.69P/E
1.33MMarket Cap

Total Valuation

USD

As of March 31, 2026, Escalon Medical Corp. carries a market capitalization of 1.33M, placing it among publicly traded companies globally. Its enterprise value stands at -352,199.78, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.33M
Enterprise Value-352,199.78

Share Statistics

As of March 31, 2026, Escalon Medical Corp. has 7.42M shares outstanding.

Shares Outstanding7.42M

Valuation Ratios

As of March 31, 2026, Escalon Medical Corp. trades at a trailing price-to-earnings ratio of 1.69. The price-to-sales ratio is 0.12, and the price-to-book ratio stands at 0.38.

PE Ratio1.69
PS Ratio0.12
PB Ratio0.38
P/TBV Ratio0.38
P/FCF Ratio-13.68
P/OCF Ratio-9.84

Financial Position

As of March 31, 2026, Escalon Medical Corp. maintains a current ratio of 2.59, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 24.37, indicating elevated leverage, while an interest coverage ratio of -53.30 demonstrates limited ability to service its debt obligations.

Current Ratio2.59
Quick Ratio1.85
Debt / Equity24.37
Debt / EBITDA-1.17
Interest Coverage-53.30

Financial Efficiency

USD

Over the twelve months ended March 31, 2026, Escalon Medical Corp. posted a return on equity (ROE) of 30.74, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) is negative at -23.26, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 29.05, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 46.88, useful for judging operating efficiency across full business cycles. The company generates approximately 293,470.38 in revenue per employee across its workforce of 39.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.94 indicates how many times Escalon Medical Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)30.74
Return on Assets (ROA)29.05
Return on Invested Capital (ROIC)-23.26
Return on Capital Employed (ROCE)46.88
Revenue Per Employee293,470.38
Employee Count39.00
Inventory Turnover3.94

Stock Price Statistics

USD

As of the close on November 16, 2026, Escalon Medical Corp.'s stock has gained approximately 3.83% over the past 52 weeks. The 50-day moving average sits at 0.17, while the 200-day moving average is 0.22.

52-Week Price Change3.83%
50-Day Moving Average0.17
200-Day Moving Average0.22

Income Statement

USD

Over the twelve months ended March 31, 2026, Escalon Medical Corp. generated 11.45M in revenue and converted that into 1.85M in net income, yielding earnings per share of 0.17. EBITDA reached -866,906.00, while operating income came in at -895,045.00.

Revenue11.45M
Gross Profit4.75M
Operating Income-895,045.00
Pretax Income1.85M
Net Income1.85M
EBITDA-866,906.00
EBIT-895,045.00
Earnings Per Share (EPS)0.17

Balance Sheet

USD

As of March 31, 2026, Escalon Medical Corp. holds 3.34M in cash and equivalents against 1.01M in total debt, resulting in a net debt position of -3.20M. Total book value stands at 3.50M, with working capital of 4.03M providing operational flexibility.

Cash & Cash Equivalents3.34M
Total Debt1.01M
Net Debt-3.20M
Equity (Book Value)3.50M
Book Value Per Share0.47
Working Capital4.03M

Cash Flow

USD

Escalon Medical Corp. produced -135,664.00 in operating cash flow over the twelve months ended March 31, 2026. After subtracting -8,301.00 in capital expenditures, free cash flow totaled -143,965.00 - equivalent to -0.02 per share.

Operating Cash Flow-135,664.00
Capital Expenditures-8,301.00
Free Cash Flow-143,965.00
FCF Per Share-0.02

Margins

Over the twelve months ended March 31, 2026, Escalon Medical Corp. posted a gross margin of 41.48, reflecting its pricing power and cost economics. The operating margin of -7.82 and net profit margin of 16.18 provide insight into operational efficiency.

Gross Margin41.48
Operating Margin-7.82
Pretax Margin16.18
Profit Margin16.18
EBITDA Margin-7.57

Dividends & Yields

These figures cover the twelve months ended March 31, 2026. The dividend payout ratio of -133.89 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -7.31: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 10.18, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Escalon Medical Corp. shareholders.

Payout Ratio-133.89
Shareholder Yield10.18
FCF Yield-7.31

Stock Splits

Escalon Medical Corp.'s most recent stock split took place on November 24, 1997 with a 4:1 split ratio.

Last Split Date11/24/1997
Split Ratio4:1

Scores

As of March 31, 2026, Escalon Medical Corp. has an Altman Z-Score of -10.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-10.31